Suppr超能文献

静脉溶栓期间血压早期变化对急性缺血性脑卒中患者预后的影响

Effects of Early Changes in Blood Pressure During Intravenous Thrombolysis on the Prognosis of Acute Ischemic Stroke Patients.

作者信息

Wang Zhong-Xiu, Wang Chao, Zhang Peng, Qu Yang, Guo Zhen-Ni, Yang Yi

机构信息

Department of Neurology, Stroke Center and Clinical Trial and Research Center for Stroke, The First Hospital of Jilin University, Changchun, China.

China National Comprehensive Stroke Center, Changchun, China.

出版信息

Front Aging Neurosci. 2020 Dec 4;12:601471. doi: 10.3389/fnagi.2020.601471. eCollection 2020.

Abstract

: Intravenous thrombolysis (IVT) therapy is currently one of the best medical treatments available for patients with acute ischemic stroke. Studies have shown that blood pressure (BP) changes in patients treated with IVT are significantly correlated with prognosis. : Our study aimed to determine the relationship between BP changes during recombinant tissue plasminogen activator (rt-PA) infusion and the 3-month prognosis evaluated using the modified Rankin Scale (mRS) and determine the factors influencing BP changes during rt-PA infusion. : Consecutive patients who were treated with IVT and admitted to our stroke center between May 2015 and October 2017 were analyzed retrospectively. Patients were divided into two groups according to their 3-month prognosis status: patients with mRS ≤ 2 were defined as "favorable outcome group" and those with mRS ≥ 3 as "unfavorable outcome group". First, the factors affecting prognosis after thrombolysis were analyzed. Second, we analyzed the relationship between BP and the prognosis. BP was taken before and at regular intervals of 15 min during the rt-PA infusion (1 h). The average value of BP during thrombolysis was calculated and compared to the baseline BP. BP decrease was defined as the difference between the baseline BP and the average BP, provided it was greater than 0 mmHg. Third, univariate and multivariate analyses were performed to identify factors that may contribute to BP decrease. : In total, 458 patients were included. Patients with a lower baseline National Institute of Health Stroke Scale (NIHSS) score (8.25 ± 5.57 vs. 13.51 ± 7.42, < 0.001), a higher Alberta Stroke Program Early CT Score (ASPECTS; 8.65 ± 1.82 vs. 8.13 ± 2.00, = 0.005), decreased BP during thrombolysis (69.4% vs. 59.8%, = 0.037), and steady BP (SD < 10 mmHg) were more likely to have a favorable outcome (73.9% vs. 60.6%, = 0.019). High baseline BP (OR > 1), hypertension history (OR < 1), and baseline ASPECTS (OR > 1) were independent factors of BP change during thrombolysis. : Patients with decreased or steady BP during thrombolysis were more likely to have a favorable outcome. Baseline ASPECTS, baseline NIHSS score, and hypertension history influenced BP changes during thrombolysis.

摘要

静脉溶栓(IVT)治疗目前是急性缺血性脑卒中患者可用的最佳药物治疗方法之一。研究表明,接受IVT治疗的患者血压(BP)变化与预后显著相关。:我们的研究旨在确定重组组织型纤溶酶原激活剂(rt-PA)输注期间血压变化与使用改良Rankin量表(mRS)评估的3个月预后之间的关系,并确定影响rt-PA输注期间血压变化的因素。:回顾性分析了2015年5月至2017年10月期间在我们的卒中中心接受IVT治疗并入院的连续患者。根据患者3个月的预后状况将其分为两组:mRS≤2的患者定义为“良好预后组”,mRS≥3的患者定义为“不良预后组”。首先,分析影响溶栓后预后的因素。其次,我们分析了血压与预后之间的关系。在rt-PA输注(1小时)期间,在输注前和每隔15分钟测量一次血压。计算溶栓期间血压的平均值并与基线血压进行比较。血压下降定义为基线血压与平均血压之间的差值,前提是该差值大于0 mmHg。第三,进行单因素和多因素分析以确定可能导致血压下降的因素。:总共纳入了458例患者。基线美国国立卫生研究院卒中量表(NIHSS)评分较低的患者(8.25±5.57对13.51±7.42,<0.001)、阿尔伯塔卒中项目早期CT评分(ASPECTS)较高的患者(8.65±1.82对8.13±2.00,=0.005)、溶栓期间血压下降的患者(69.4%对59.8%,=0.037)以及血压稳定(标准差<10 mmHg)的患者更有可能获得良好预后(73.9%对60.6%,=0.019)。高基线血压(OR>1)、高血压病史(OR<1)和基线ASPECTS(OR>1)是溶栓期间血压变化的独立因素。:溶栓期间血压下降或稳定的患者更有可能获得良好预后。基线ASPECTS、基线NIHSS评分和高血压病史影响溶栓期间的血压变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e020/7746539/22b4f0d71f1d/fnagi-12-601471-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验